Detalhe da pesquisa
1.
Goal achievement of HbA1c and LDL-cholesterol in a randomized trial comparing colesevelam with ezetimibe: GOAL-RCT.
Diabetes Obes Metab
; 22(10): 1722-1728, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32406601
2.
Glycemic Improvement with a Fixed-dose combination of DPP-4 inhibitor + metformin in patients with Type 2 diabetes (GIFT study).
Diabetes Obes Metab
; 20(1): 195-199, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28640433
3.
Randomized Comparison of Initiating the Fixed-Ratio Combination of iGlarLixi or Biosimilar Insulin Glargine Together With Gliclazide in Participants of South Asian Origin With Type 2 Diabetes: VARIATION 2 SA Trial.
Can J Diabetes
; 46(5): 495-502, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35752566
4.
Lowest Glucose Variability and Hypoglycemia Are Observed With the Combination of a GLP-1 Receptor Agonist and Basal Insulin (VARIATION Study).
Diabetes Care
; 40(2): 194-200, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-27913575
5.
Randomized Trial of Long-Acting Insulin Glargine Titration Web Tool (LTHome) Versus Enhanced Usual Therapy of Glargine Titration (INNOVATE Trial).
Diabetes Technol Ther
; 18(10): 610-615, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27652718
6.
The Need Associated with Diabetes Primary Care and the Impact of Referral to a Specialist-Centered Multidisciplinary Diabetes Program (the NADIR Study).
Can J Diabetes
; 40(2): 120-5, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26612189